Insights

Acquisition Opportunity Grünenthal recently acquired Valinor Pharma, including the OIC therapy Movantik, for $250M, signaling a strategic expansion into pain management. This acquisition provides a foothold in the US market and a new product offering to leverage for increased sales.

Global Production Investment Investing over $87M in updating manufacturing facilities in South America demonstrates Grünenthal's commitment to expanding its global production capacity. Expanding and modernizing facilities can lead to increased production output and potentially open up new sales channels in the Latin American region.

Innovative Partnerships Collaborating with companies like Catalent and RealizedCare showcases Grünenthal's openness to innovation and strategic partnerships. These collaborations can result in the development of new products and services, offering additional sales opportunities through expanded product portfolios.

Research Investment Awarding grants like the EFIC-Grünenthal Grant demonstrates a commitment to research and development in pain management. This investment in research can lead to the discovery of new treatments or therapies, potentially creating new sales avenues through innovative products.

Strategic Investor Partnerships Partnering with RealizedCare as a strategic investor indicates a focus on investing in companies that align with Grünenthal's vision of a world free of pain. These partnerships can lead to synergies in product development and market expansion, presenting new sales opportunities through shared resources.

Grünenthal Group Tech Stack

Grünenthal Group uses 8 technology products and services including NetApp, Oracle, Jupyter, and more. Explore Grünenthal Group's tech stack below.

  • NetApp
    Data Management
  • Oracle
    Enterprise
  • Jupyter
    File Sharing
  • jQuery UI
    Javascript Libraries
  • Informa
    Miscellaneous
  • Concur
    Travel And Expense Management
  • MediaElement.js
    Video Players
  • VMware
    Virtualisation Software

Media & News

Grünenthal Group's Email Address Formats

Grünenthal Group uses at least 1 format(s):
Grünenthal Group Email FormatsExamplePercentage
First.Last@grunenthal.comJohn.Doe@grunenthal.com
92%
First.Middle@grunenthal.comJohn.Michael@grunenthal.com
5%
Last.First@grunenthal.comDoe.John@grunenthal.com
2%
First.MiddleLast@grunenthal.comJohn.MichaelDoe@grunenthal.com
1%

Frequently Asked Questions

Where is Grünenthal Group's headquarters located?

Minus sign iconPlus sign icon
Grünenthal Group's main headquarters is located at Zieglerstr. 6 Aachen, 52078 DE. The company has employees across 6 continents, including EuropeSouth AmericaNorth America.

What is Grünenthal Group's phone number?

Minus sign iconPlus sign icon
You can contact Grünenthal Group's main corporate office by phone at +49-241-5690. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Grünenthal Group's official website and social media links?

Minus sign iconPlus sign icon
Grünenthal Group's official website is grunenthal.com and has social profiles on LinkedIn.

How much revenue does Grünenthal Group generate?

Minus sign iconPlus sign icon
As of July 2024, Grünenthal Group's annual revenue reached $750M.

What is Grünenthal Group's NAICS code?

Minus sign iconPlus sign icon
Grünenthal Group's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Grünenthal Group have currently?

Minus sign iconPlus sign icon
As of July 2024, Grünenthal Group has approximately 4.5K employees across 6 continents, including EuropeSouth AmericaNorth America. Key team members include Chief Commercial Officer Cco: J. V. D. K.Chief Scientific Officer And Member Of The Corporate Executive Board: J. A.Chief Financial Officer, Member Of The Executive Board: F. R.. Explore Grünenthal Group's employee directory with LeadIQ.

What industry does Grünenthal Group belong to?

Minus sign iconPlus sign icon
Grünenthal Group operates in the Pharmaceutical Manufacturing industry.

What technology does Grünenthal Group use?

Minus sign iconPlus sign icon
Grünenthal Group's tech stack includes NetAppOracleJupyterjQuery UIInformaConcurMediaElement.jsVMware.

What is Grünenthal Group's email format?

Minus sign iconPlus sign icon
Grünenthal Group's email format typically follows the pattern of . Find more Grünenthal Group email formats with LeadIQ.

When was Grünenthal Group founded?

Minus sign iconPlus sign icon
Grünenthal Group was founded in 1946.
Grünenthal Group

Grünenthal Group

Pharmaceutical ManufacturingAachen, Germany1001-5000 Employees

Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 27 countries across Europe, Latin America and the US. Our products are available in approx. 100 countries. In 2023, Grünenthal employed around 4,400 people and achieved revenues of € 1.8 bn.

More Information on www.grunenthal.com 

Jobs & Career: http://careers.grunenthal.com/

Imprint: https://www.grunenthal.com/en/footer-links/imprint

Privacy: https://www.grunenthal.com/en/footer-links/privacy-statement-social-media

This company profile is managed by Global Communications. 

In our commitment to transparency and the principles outlined in our digital ethics charter, Grünenthal wishes to inform you that generative artificial intelligence technologies are occasionally used to enhance content on this channel. Each content piece has been reviewed and edited by a team member before publication to ensure accuracy.

Section iconCompany Overview

Headquarters
Zieglerstr. 6 Aachen, 52078 DE
Phone number
+49-241-5690
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1946
Employees
1001-5000

Section iconFunding & Financials

  • $100M$1B

    Grünenthal Group's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M$1B

    Grünenthal Group's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.